RAYMOND BERGAN, MD
Osteopathic Medicine at Saint Clair St, Chicago, IL
License number
Illinois 036-099084
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
675 N Saint Clair St SUITE 100, Chicago, IL 60611
Phone
(312) 695-0990
(312) 695-1106 (Fax)
(312) 695-1106 (Fax)
Personal information
See more information about RAYMOND BERGAN at radaris.comName
Address
Phone
1873 N Fremont St #1, Chicago, IL 60614
1454 Glenlake Ave, Chicago, IL 60660
1873 Fremont St, Chicago, IL 60614
675 Saint Clair St, Chicago, IL 60611
Organization information
See more information about RAYMOND BERGAN at bizstanding.comRaymond Bergan MD
675 N Saint Clair St STE 21-100, Chicago, IL 60611
Categories:
Physicians & Surgeons
Phone:
(312) 695-0990 (Phone)
Products:
Military & Veteran's Services
Payment options:
All Major Cards Accepted, American Express, MasterCard, ...
Professional information
See more information about RAYMOND BERGAN at trustoria.com
Raymond Bergan, Chicago IL
Raymond Bergan, Chicago IL
Specialties:
Internal Medicine, Medical Oncology, Hematology & Oncology
Work:
Jesse Brown Va Medical Center
820 S Damen Ave, Chicago, IL 60612 312-695-7950
675 N Saint Clair St, Chicago, IL 60611
820 S Damen Ave, Chicago, IL 60612 312-695-7950
675 N Saint Clair St, Chicago, IL 60611
Education:
Upstate Medical University Physical Medicine and Rehabilitation (1987)
Inhibition And Treatment Of Prostate Cancer Metastasis
Inhibition And Treatment Of Prostate Cancer Metastasis
US Patent:
2012028, Nov 8, 2012
Filed:
Jul 23, 2012
Appl. No.:
13/555537
Inventors:
Raymond C. Bergan - Chicago IL, US
Karl A. Scheidt - Evanston IL, US
Karl A. Scheidt - Evanston IL, US
Assignee:
NORTHWESTERN UNIVERSITY - Evanston IL
International Classification:
A61K 31/352, A61K 31/7105, C12N 5/09, C12N 9/99, A61P 35/04, C07D 311/36, G01N 33/573, C12Q 1/68, G01N 21/00, A61K 31/7088, C12Q 1/48
US Classification:
514 44 A, 514456, 435375, 435184, 435 15, 549403, 435 74, 435 613, 435 612, 435 61
Abstract:
The present invention provides compounds and methods of inhibiting and treating metastatic prostate cancer. The compounds include MEK4 inhibitors. In another aspect the invention provides methods of identifying inhibitors of metastatic prostate cancer by screening for inhibitors of MEK4.
Inhibition And Treatment Of Prostate Cancer Metastasis
Inhibition And Treatment Of Prostate Cancer Metastasis
US Patent:
2009012, May 14, 2009
Filed:
Oct 13, 2008
Appl. No.:
12/250351
Inventors:
Raymond C. Bergan - Chicago IL, US
Karl A. Scheidt - Evanston IL, US
Karl A. Scheidt - Evanston IL, US
Assignee:
NORTHWESTERN UNIVERSITY - Evanston IL
International Classification:
A61K 31/7105, C12N 5/08, G01N 33/53, A61K 31/352, A61P 35/00
US Classification:
514 44, 435375, 435 71, 514456
Abstract:
The present invention provides compounds and methods of inhibiting and treating metastatic prostate cancer. The compounds include MEK4 inhibitors. In another aspect the invention provides methods of identifying inhibitors of metastatic prostate cancer by screening for inhibitors of MEK4.
Inhibition And Treatment Of Prostate Cancer Metastasis
Inhibition And Treatment Of Prostate Cancer Metastasis
US Patent:
8481760, Jul 9, 2013
Filed:
Oct 13, 2009
Appl. No.:
12/578137
Inventors:
Raymond C. Bergan - Chicago IL, US
Karl A. Scheidt - Evanston IL, US
Karl A. Scheidt - Evanston IL, US
Assignee:
Northwestern University - Evanston IL
International Classification:
C07D 311/00, A61K 31/35
US Classification:
549403, 514456
Abstract:
The present invention provides compounds and methods of inhibiting and treating metastatic prostate cancer. The compounds include MEK4 inhibitors. In another aspect the invention provides methods of identifying inhibitors of metastatic prostate cancer by screening for inhibitors of MEK4.